● Recruiting

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Condition: Indolent Systemic Mastocytosis · Sponsor: Blueprint Medicines Corporation

PhaseN/A

Planned participants80

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a non-interventional study assessing the effectiveness of avapritinib (BLU-285) in the management of ISM in real-world settings in Germany. The study also seeks to address the existing data gap in the natural history and management of participants with ISM. The study is designed to follow each participant up to a maximum of 24 months.

This description comes directly from the study's public registry record.

Talk to the study team

Blueprint Medicines, EU Contact · +31 85 064 4001 · medinfoeurope@blueprintmedicines.com

Always discuss trial participation with your own doctor first.

Locations (8)

Charité Universitätmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie	Berlin, Germany	Recruiting
Katholisches Klinikum Bochum	Bochum, Germany	Recruiting
MVZ Klinikum Deggendorf	Deggendorf, Germany	Recruiting
Universitätsklinikum Carl Gustav Carus Dresden Klinik und Poliklinik für Dermatologie	Dresden, Germany	Recruiting
University Medical Center Goettingen - Georg August University of Goettingen	Göttingen, Germany	Recruiting
Universitats-Hautklinik Tubingen, Studienzentrum lmmundermatologie	Tübingen, Germany	Recruiting
HNO-Gemeinschaftspraxis Wiesbaden, GEKA Gesellschaft für Experimentelle und Klinische Atemwegsforschung mbH, Zentrum für Rhinologie und Allergologie	Wiesbaden, Germany	Recruiting
Helios Universitätsklinikum Wuppertal	Wuppertal, Germany	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07255638